| SC 13G | 2024-04-11 | RA CAPITAL MANAGEMENT, L.P. | CervoMed Inc. | 825,373 | 10.0% | EDGAR |
| SC 13G/A | 2024-03-06 | AI EIPP Holdings LLC | CervoMed Inc. | 42,556 | 0.7% | EDGAR |
| SC 13D/A | 2024-02-28 | BOGER JOSHUA S | CervoMed Inc. | 1,057,268 | 17.1% | EDGAR |
| SC 13G/A | 2024-02-14 | AI EIPP Holdings LLC | CervoMed Inc. | 428,203 | 7.5% | EDGAR |
| SC 13D | 2024-02-09 | BOGER JOSHUA S | CervoMed Inc. | 561,309 | 9.9% | EDGAR |
| SC 13D | 2023-08-28 | ALAM JOHN J | CervoMed Inc. | 1,484,078 | 26.2% | EDGAR |
| SC 13D | 2023-08-28 | ZAVRL FRANK | CervoMed Inc. | 365,621 | 6.4% | EDGAR |
| SC 13G | 2023-08-28 | AI EIPP Holdings LLC | CervoMed Inc. | 568,811 | 10.0% | EDGAR |
| SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | Diffusion Pharmaceuticals Inc. | 1,755,156 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Anson Funds Management LP | Diffusion Pharmaceuticals Inc. | 640,270 | 1.6% | EDGAR |
| SC 13G/A | 2020-01-09 | SABBY MANAGEMENT, LLC | Diffusion Pharmaceuticals Inc. | 1,667,574 | 5.0% | EDGAR |
| SC 13G | 2019-12-20 | INTRACOASTAL CAPITAL, LLC | Diffusion Pharmaceuticals Inc. | 1,607,936 | 5.0% | EDGAR |
| SC 13G | 2019-11-25 | INTRACOASTAL CAPITAL, LLC | Diffusion Pharmaceuticals Inc. | 526,401 | 5.0% | EDGAR |
| SC 13G | 2019-06-03 | ARMISTICE CAPITAL, LLC | Diffusion Pharmaceuticals Inc. | 256,516 | 5.5% | EDGAR |
| SC 13G | 2019-06-03 | Anson Funds Management LP | Diffusion Pharmaceuticals Inc. | 439,020 | 9.4% | EDGAR |
| SC 13G | 2019-05-28 | SABBY MANAGEMENT, LLC | Diffusion Pharmaceuticals Inc. | 439,020 | 9.4% | EDGAR |
| SC 13G/A | 2018-01-29 | Ally Bridge Group Capital Partners II, L.P. | Diffusion Pharmaceuticals Inc. | 1,860,055 | 3.7% | EDGAR |
| SC 13G/A | 2017-04-06 | Ally Bridge Group Capital Partners II, L.P. | Diffusion Pharmaceuticals Inc. | 1,133,281 | 10.0% | EDGAR |
| SC 13G/A | 2017-02-02 | Smith David E | Diffusion Pharmaceuticals Inc. | 108,500 | - | EDGAR |
| SC 13G/A | 2016-02-11 | Smith David E | Diffusion Pharmaceuticals Inc. | 1,085,000 | - | EDGAR |